March 27 (Reuters) - Bausch + Lomb BLCO.TO said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known.
The company said it is recalling these lenses, which are part of its enVista platform, out of an abundance of caution, and was looking to identify a root cause.
"As much as we believe in the enVista platform, patient safety will always be our number one priority," said CEO Brent Saunders.
The company's intraocular or surgically implanted lenses are used in cataract surgery to replace the natural clouded lens in the eye.
Bausch + Lomb said there have been reports of an inflammatory reaction in some patients with these lenses, adding the patients responded quickly to treatment, with none requiring removal of the lens.
The company said it is informing eye care professionals about the impacted lots and return protocols for the product.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shailesh Kuber)
((Christy.Santhosh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.